| Primary Device ID | 04250289503075 | 
| NIH Device Record Key | 803d45f3-f428-45a8-b3fb-9fe641af702b | 
| Commercial Distribution Status | In Commercial Distribution | 
| Brand Name | AESKULISA® ß2-Glyco-A | 
| Version Model Number | 7205US | 
| Catalog Number | 7205US | 
| Company DUNS | 341714388 | 
| Company Name | Aesku.Diagnostics GmbH & Co. KG | 
| Device Count | 1 | 
| DM Exempt | false | 
| Pre-market Exempt | false | 
| MRI Safety Status | Labeling does not contain MRI Safety Information | 
| Human Cell/Tissue Product | false | 
| Device Kit | false | 
| Device Combination Product | false | 
| Single Use | true | 
| Lot Batch | true | 
| Serial Number | false | 
| Manufacturing Date | false | 
| Expiration Date | true | 
| Donation Id Number | false | 
| Contains Natural Rubber Latex | false | 
| Labeled No Natural Rubber Latex | false | 
| RX Perscription | false | 
| OTC Over-The-Counter | false | 
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius | 
| Device Issuing Agency | Device ID | 
|---|---|
| GS1 | 04250289503075 [Primary] | 
| MSV | System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi) | 
| Steralize Prior To Use | false | 
| Device Is Sterile | false | 
| Public Version Status | Update | 
| Device Record Status | Published | 
| Public Version Number | 3 | 
| Public Version Date | 2018-07-06 | 
| Device Publish Date | 2017-03-01 | 
| 04250289503075 | AESKULISA b2 Glyco-A is a solid phase enzyme immunoassay employing native b2 glycoprotein I high | 
| 04250289502825 | AESKULISA β2 Glyco-A is a solid phase enzyme immunoassay employing native β2 glycoprotein I hi | 
| 04250289500852 | AESKULISA β2 Glyco-A is a solid phase enzyme immunoassay employing native β2 glycoprotein I hi | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  AESKULISA  76374617  2878292 Live/Registered | Matthias, Torsten 2002-02-22 |